- Home
- INFU vs BTMD Comparison
INFU vs BTMD Comparison
Compare INFU & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- BTMD
- Stock Information
- Founded
- INFU 2005
- BTMD 2012
- Country
- INFU United States
- BTMD United States
- Employees
- INFU N/A
- BTMD N/A
- Industry
- INFU Medical/Dental Instruments
- BTMD Medicinal Chemicals and Botanical Products
- Sector
- INFU Health Care
- BTMD Health Care
- Exchange
- INFU Nasdaq
- BTMD Nasdaq
- Market Cap
- INFU 189.2M
- BTMD 198.2M
- IPO Year
- INFU N/A
- BTMD N/A
- Fundamental
- Price
- INFU $8.14
- BTMD $5.91
- Analyst Decision
- INFU
- BTMD Strong Buy
- Analyst Count
- INFU 0
- BTMD 5
- Target Price
- INFU N/A
- BTMD $9.11
- AVG Volume (30 Days)
- INFU 72.2K
- BTMD 152.7K
- Earning Date
- INFU 11-07-2024
- BTMD 11-12-2024
- Dividend Yield
- INFU N/A
- BTMD N/A
- EPS Growth
- INFU 60.96
- BTMD N/A
- EPS
- INFU 0.07
- BTMD 0.21
- Revenue
- INFU $132,783,999.00
- BTMD $193,060,000.00
- Revenue This Year
- INFU $10.49
- BTMD $9.27
- Revenue Next Year
- INFU $8.84
- BTMD $14.82
- P/E Ratio
- INFU $119.01
- BTMD $29.01
- Revenue Growth
- INFU 8.17
- BTMD 4.84
- 52 Week Low
- INFU $5.74
- BTMD $3.65
- 52 Week High
- INFU $10.99
- BTMD $8.44
- Technical
- Relative Strength Index (RSI)
- INFU 39.16
- BTMD 39.82
- Support Level
- INFU $7.54
- BTMD $6.21
- Resistance Level
- INFU $9.18
- BTMD $6.60
- Average True Range (ATR)
- INFU 0.40
- BTMD 0.31
- MACD
- INFU -0.20
- BTMD -0.11
- Stochastic Oscillator
- INFU 18.41
- BTMD 0.81
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.